about
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its...
Read More
0.83
0.02
(2.47%)
176.3K
XNAS Volume
XNAS 08 Aug, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for Cue Biopharma Inc is on 19 Aug 2025 for the purpose of Cue Biopharma Inc Second Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Neutral
Cue Biopharma Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..